Pharmafocus
Pharmaceutical Industry news, analysis and insights
Alexander Gebauer from Galimedix Therapeutics talks to Pharmafocus about the link between the two diseases and what the treatment landscape for both could look like in the future
Ameet Nathwani at Dewpoint Therapeutics considers the current treatment landscape for both type 1 and type 2 diabetes, as well as evaluating the use of biomolecular condensates as a potential treatment option
Stefan Woxström at AstraZeneca Europe and Canada tells Pharmafocus about the link between climate change and human health, as well as considering how the pharma industry has contributed to the climate crisis
Pharmafocus talks to Scott Curley about the risks of CVD and the imporance of getting the right treatment at the right time
Professor Henrik Van Poppel, member of the expert group for the Let's Talk Prostate Cancer initiative tells Pharmafocus about its new campaign